Kevin Young
2011
In 2011, Kevin Young earned a total compensation of $4.7M as Former Executive Vice President, Commercial Operations at Gilead Sciences, a 12% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $743,243 |
|---|---|
| Option Awards | $1,622,613 |
| Salary | $711,260 |
| Stock Awards | $1,614,541 |
| Other | $5,000 |
| Total | $4,696,657 |
Young received $1.6M in option awards, accounting for 35% of the total pay in 2011.
Young also received $743.2K in non-equity incentive plan, $711.3K in salary, $1.6M in stock awards and $5K in other compensation.
Rankings
In 2011, Kevin Young's compensation ranked 1,190th out of 10,747 executives tracked by ExecPay. In other words, Young earned more than 88.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,190 out of 10,747 | 89th |
Division Manufacturing | 446 out of 3,958 | 89th |
Major group Chemicals And Allied Products | 104 out of 1,034 | 90th |
Industry group Drugs | 59 out of 782 | 93rd |
Industry Biological Products, Except Diagnostic Substances | 7 out of 162 | 96th |
Source: SEC filing on March 24, 2014.
Young's colleagues
We found four more compensation records of executives who worked with Kevin Young at Gilead Sciences in 2011.